| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.094 | 0.6 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.098 | 0.6 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |